{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T09:55:37Z","timestamp":1763200537322,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejogrb.2020.10.032","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T16:46:46Z","timestamp":1602866806000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Post-exposure prophylaxis for Blood-Borne Viral (BBV) Infections"],"prefix":"10.1016","volume":"255","author":[{"given":"Victor N.","family":"Chilaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudaina","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin C.","family":"Konje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2020.10.032_bib0005","doi-asserted-by":"crossref","DOI":"10.1086\/502439","article-title":"Estimate of the Annual Number of Percutaneous Injuries Among Hospital-Based Healthcare Workers in the United States, 1997\u20131998","author":"Panlilio","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajic.2004.11.011","article-title":"Infection risks following accidental exposure to blood or body fluids in health care workers: A review of pathogens transmitted in published cases","author":"Tarantola","year":"2006","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0015","doi-asserted-by":"crossref","DOI":"10.3310\/hta21720","article-title":"Preventing blood-borne virus infection in people who inject drugs in the UK: Systematic review, stakeholder interviews, psychosocial intervention development and feasibility randomised controlled trial","author":"Gilchrist","year":"2017","journal-title":"Health Technol Assess (Rockv)"},{"year":"2001","series-title":"Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis","key":"10.1016\/j.ejogrb.2020.10.032_bib0020"},{"year":"2005","series-title":"Sharps injuries: Assessing the burden of disease from sharps injuries to health-care workers at national and local levels","author":"Rapiti","key":"10.1016\/j.ejogrb.2020.10.032_bib0025"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0030","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: Recommendations of the advisory committee on immunization practices","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Reports"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0035","article-title":"Risk of professional accidental exposure to biological agents in health care workers: A retrospective analysis carried out in a Southern Italian tertiary hospital","author":"Bianco","year":"2019","journal-title":"Infez Med"},{"volume":"30329","year":"2019","author":"Centers for Disease control and Prevention","key":"10.1016\/j.ejogrb.2020.10.032_bib0040"},{"issue":"43","key":"10.1016\/j.ejogrb.2020.10.032_bib0045","first-page":"107","article-title":"Postexposure management of healthcare personnel to infectious diseases","volume":"2015","author":"Bader","year":"1995","journal-title":"Hosp Pract"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(10)60936-1","article-title":"Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study","author":"Montaner","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/0956462416641813","article-title":"UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015","volume":"27","author":"Cresswell","year":"2016","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0060","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000000298","article-title":"Estimating per-act HIV transmission risk: A systematic review","author":"Patel","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0065","article-title":"European AIDS clinical society guidelines. Version 10.0. November 2019","author":"European AIDS Clinical Society E","year":"2019","journal-title":"IEEE Trans Sonics Ultrason"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0070","article-title":"Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings","volume":"2007","author":"Siegel","year":"2007","journal-title":"Am J Infect Control"},{"year":"2008","series-title":"HIV post-exposure prophylaxis: Guidance from the UK Chief Medical Officers\u2019 Expert Advisory Group on AIDS","author":"Department of Health","key":"10.1016\/j.ejogrb.2020.10.032_bib0075"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/672271","article-title":"Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis","volume":"34","author":"Kuhar","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"year":"2016","series-title":"Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV","author":"CDC","key":"10.1016\/j.ejogrb.2020.10.032_bib0085"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0090","article-title":"Post-exposure prophylaxis with highly active antiretroviral therapy could not protect macaques from infection with SIV\/HIV chimera","author":"Le Grand","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0095","doi-asserted-by":"crossref","DOI":"10.1097\/COH.0b013e32833a0b69","article-title":"Antiretroviral drug concentrations in the male and female genital tract: Implications for the sexual transmission of HIV","author":"Taylor","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0100","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc1807653","article-title":"Neural-tube defects with dolutegravir treatment from the time of conception","author":"Zash","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0105","unstructured":"CDC. Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir \u2013 Implications for HIV Post-exposure Prophylaxis (PEP). n.d."},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0110","article-title":"CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management","author":"Schillie","year":"2013","journal-title":"MMWR Recomm Reports"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/occmed\/kqr136","article-title":"Hepatitis B prevention, diagnosis, treatment and care: a review","volume":"61","author":"Aspinall","year":"2011","journal-title":"Occup Med (Chic Ill)"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0120","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.16.3.546-568.2003","article-title":"Managing occupational risks for hepatitis C transmission in the health care setting","author":"Henderson","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0125","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/173.4.822","article-title":"Effect of immune globulin on the prevention of experimental hepatitis C virus infection","author":"Krawczynski","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/S0011-8532(03)00041-7","article-title":"Occupational exposures to human immunodeficiency virus, hepatitis B virus, and hepatitis C virus: Risk, prevention, and management","author":"Cleveland","year":"2003","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0135","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Fred","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0140","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(14)60494-3","article-title":"Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): A phase 3, randomised, double-blind, placebo-controlled trial","volume":"384","author":"Jacobson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0145","article-title":"Hepatitis C Virus Postexposure prophylaxis in the healthcare worker: Why direct-acting antivirals don\u2019t change a thing","author":"Naggie","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1586\/14787210.2015.999667","article-title":"Prevention of mother-to-child transmission of Human Immunodeficiency Virus Type 1 (HIV): the role of neonatal and infant prophylaxis HHS Public Access","volume":"13","author":"Hurst","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"year":"2016","series-title":"4 Clinical Guidelines: Antiretroviral Therapy. Consol Guidel Use Antiretrovir Drugs Treat Prev HIV Infect Recomm a Public Heal Approach","author":"WHO","key":"10.1016\/j.ejogrb.2020.10.032_bib0155"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0160","doi-asserted-by":"crossref","DOI":"10.1001\/jama.283.9.1175","article-title":"Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice","author":"De Cock","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/0140-6736(92)92115-V","article-title":"Risk of human immunodeficiency virus type 1 transmission through breastfeeding","author":"Dunn","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0170","doi-asserted-by":"crossref","DOI":"10.1086\/374272","article-title":"Breast\u2010Milk Infectivity in Human Immunodeficiency Virus Type 1\u2013Infected Mothers","author":"Richardson","year":"2003","journal-title":"J Infect Dis"},{"year":"2016","series-title":"WHO | New guidelines on antenatal care for a positive pregnancy experience","author":"WHO","key":"10.1016\/j.ejogrb.2020.10.032_bib0175"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0180","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/ob.1996.v175.a75478","article-title":"Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: The French perinatal cohorts","volume":"175","author":"Mandelbrot","year":"1996","journal-title":"Am J Obstet Gynecol"},{"journal-title":"HIV Med","article-title":"British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018","year":"2019","key":"10.1016\/j.ejogrb.2020.10.032_bib0185"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0190","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1468-1293.2009.00800.x","article-title":"Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: Changing practices in Western Europe","volume":"11","author":"Thorne","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0195","article-title":"The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: A meta-analysis of 15 prospective cohort studies","author":"Andiman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0200","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0205","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.39.1.125","article-title":"Immediate zidovudine treatment protects simian immunodeficiency virus- infected newborn macaques against rapid onset of AIDS","author":"Van Rompay","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0210","article-title":"Dorenbaum A. Nevirapine: Pharmacokinetic considerations in children and pregnant women","author":"Mirochnick","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0215","doi-asserted-by":"crossref","DOI":"10.1086\/514228","article-title":"Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Pediatric AIDS Clinical Trials Group Protocol 076","author":"Eastman","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0220","doi-asserted-by":"crossref","DOI":"10.1001\/jama.288.2.181","article-title":"Time trends in primary HIV-1 drug resistance among recently infected persons","author":"Grant","year":"2002","journal-title":"J Am Med Assoc"},{"year":"2016","series-title":"The duration of breastfeeding and support from health services to improve feeding practices among mothers living with H.I.V.","key":"10.1016\/j.ejogrb.2020.10.032_bib0225"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.meegid.2016.05.041","article-title":"The global spread of HIV-1 subtype B epidemic","volume":"46","author":"Magiorkinis","year":"2016","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0235","article-title":"European Association for the Study of the Liver (EASL) 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","author":"EASL","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0240","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-150-2-200901200-00100","article-title":"National Institutes of Health consensus development conference statement: Management of hepatitis B","author":"Sorrell","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0245","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b5429","article-title":"Treatment for hepatitis B","author":"Cooke","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/flgastro-2013-100361","article-title":"Hepatitis B in pregnancy","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0255","doi-asserted-by":"crossref","DOI":"10.1038\/jp.2014.167","article-title":"Hepatitis B and C in pregnancy: A review and recommendations for care","author":"Dunkelberg","year":"2014","journal-title":"J Perinatol"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0260","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jvh.12875","article-title":"Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe","volume":"25","author":"Papatheodoridis","year":"2018","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0265","doi-asserted-by":"crossref","DOI":"10.1007\/s00535-007-2064-6","article-title":"The epidemiology of hepatitis C infection in the United States","author":"Rustgi","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0270","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(99)80383-3","article-title":"Mother-to-infant transmission of hepatitis C virus","author":"Zanetti","year":"1999","journal-title":"J. Hepatol. Suppl."},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0275","doi-asserted-by":"crossref","DOI":"10.1097\/OGX.0000000000000442","article-title":"Hepatitis C in Pregnancy: Review of Current Knowledge and Updated Recommendations for Management","author":"Page","year":"2017","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ejogrb.2020.10.032_bib0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-018-0026-5","article-title":"Management of acute HCV infection in the era of direct-acting antiviral therapy","author":"Martinello","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520306709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520306709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:49:10Z","timestamp":1759556950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211520306709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":56,"alternative-id":["S0301211520306709"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.10.032","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-exposure prophylaxis for Blood-Borne Viral (BBV) Infections","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}